Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Tender Offer - Results Announcement

11 Jun 2025 10:55

RNS Number : 4089M
Virgin Money UK PLC
11 June 2025
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) ("U.S. PERSON") OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES") OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

11 June 2025Β 

Β 

Β 

Virgin Money UK PLC

(incorporated with limited liability in England and Wales with registered number 09595911)

Legal Entity Identifier (LEI): 213800ZK9VGCYYR6O495

ANNOUNCES RESULTS OF TENDER OFFERS TO PURCHASE NOTES FOR CASH

Virgin Money UK PLC (the "Issuer") announces today the results of its invitation to holders of its outstanding Β£350,000,000 8.250 per cent. Fixed Rate Reset Perpetual Subordinated Contingent Convertible Notes (ISIN: XS2486863595) (the "8.250 per cent. Notes") and Β£350,000,000 11.000 per cent. Fixed Rate Reset Perpetual Subordinated Contingent Convertible Notes (ISIN: XS2718145779) (the "11.000 per cent. Notes", and together with the 8.250 per cent. Notes, the "Notes"), to tender such Notes for purchase by the Issuer for cash up to the Maximum Acceptance Amount, subject to the terms and conditions described in the tender offer memorandum prepared by the Issuer dated 3 June 2025 (the "Tender Offer Memorandum") (each such invitation an "Offer" and, together, the "Offers"). Capitalised terms used but not defined in this announcement have the meanings given to them in the Tender Offer Memorandum. This announcement must be read in conjunction with the Tender Offer Memorandum.

As announced by the Issuer on 4 June 2025, the Maximum Acceptance Amount is Β£700,000,000, and, as the Maximum Acceptance Amount is equal to the aggregate principal amount of the Notes, the Issuer will accept for purchase any validly tendered Notes up to the Maximum Acceptance Amount without such Notes being scaled by a Scaling Factor.

The Expiration Deadline for each Offer was 4.00 p.m. (London time) on 10 June 2025. Following the Expiration Deadline, the Issuer hereby announces that the New Financing Condition has been satisfied and, therefore, it will accept all valid tenders of Notes for purchase pursuant to the Offers. Accordingly, the aggregate principal amount of the Notes validly tendered and accepted for purchase pursuant to the Offers is Β£519,778,000 (representing 74.25 per cent. of the principal amount of the Notes outstanding), comprising Β£339,925,000 in respect of the 8.250 per cent. Notes (representing 97.12 per cent. of the principal amount of the 8.250 per cent. Notes outstanding) and Β£179,853,000 in respect of the 11.000 per cent. Notes (representing 51.39 per cent. of the principal amount of the 11.000 per cent. Notes outstanding).

Settlement of the Offers and payment of the Purchase Price and Accrued Interest Payment in respect of the Notes accepted for purchase is expected to take place on 17 June 2025. Notes that are not tendered and accepted for purchase pursuant to the Offers will remain outstanding.

Dealer Managers

J.P. Morgan Securities plc

25 Bank StreetCanary WharfLondon E14 5JPUnited Kingdom

Β 

Telephone: +44 (0) 20 7134 2468

Email: liability_management_EMEA@jpmorgan.com

Attention: EMEA Liability Management Group

Lloyds Bank Corporate Markets plc

33 Old Broad Street

London EC2N 1HZ

United Kingdom

Β 

Β 

Telephone: +44 (0) 20 7158 1726 / 1719

Email: LBCMLiabilityManagement@lloydsbanking.com

Attention: Liability Management

Β 

Β 

Β 

NatWest Markets Plc

250 Bishopsgate

London EC2M 4AA

United Kingdom

Β 

Telephone: +44 (0) 20 7678 5222

Email: NWMLiabilityManagement@natwestmarkets.com

Attention: Liability Management

Β 

Β 

Tender Agent

Kroll Issuer Services Limited The News Building

3 London Bridge Street

London

SE1 9SG

United Kingdom

Β 

Telephone: +44 (0) 20 7704 0880

Attention: Owen Morris / Scott Boswell

Email: virginmoney@is.kroll.com

Website: https://deals.is.kroll.com/virginmoney-tender

Β 

DISCLAIMER

Β 

The offer period for the Offers has now expired. No further tenders of any Notes may be made pursuant to the Offers. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer to acquire or exchange any securities is being made pursuant to this announcement. This announcement and the Tender Offer Memorandum contain important information, which must be read carefully. None of the Issuer, the Dealer Managers or the Tender Agent or their respective directors, employees or affiliates will have any liability or responsibility in respect of any decision of a Noteholder as to whether to participate in the Offers. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum come into are required by each of the Issuer, the Group, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

Β 

Questions and requests for assistance in connection with the Offers may be directed to the Dealer Managers, the contact details for which are above.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RTEFIFEARVILLIE
Date   Source Headline
19th Jun 20264:43 pmRNSPublication of Final Terms
15th Jun 20261:30 pmRNSNotice to Covered Bondholders
15th Jun 202612:40 pmRNSPublication of a Supplementary Prospectus
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.